Chemring Group /£CHG

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Chemring Group

Founded in 1905, Chemring Group PLC is a global business specializing in the manufacture of technology products and services for defense, security, and aerospace markets. Operating out of its headquarters in Romsey, United Hrvatski

Ticker

£CHG

Primary listing

LSE

Employees

2,700

Chemring Group Metrics

BasicAdvanced
£1.4B
33.76
£0.16
0.62
£0.08
1.49%

What the Analysts think about Chemring Group

Analyst ratings (Buy, Hold, Sell) for Chemring Group stock.

Bulls say / Bears say

Chemring's order intake jumped 42% year-on-year to £488 million in H1 2025, lifting the order book to a record £1.3 billion, with underlying EBITDA up 12% to £40.4 million and margins rising to 11.6% (Investing.com).
Shares rose 3% after Roke was chosen as the prime contractor for the UK MoD's multi-year STORM missile defence framework, ensuring expected revenue of over £250 million by FY28 and improving Sensors & Information coverage (Investing.com).
RBC Capital Markets started coverage with an Outperform rating and a £5.00 price target, noting Chemring's robust 67.36% gross margin, expected 8% sales and 12% EPS compound annual growth rates through 2030, and strong position in the NATO rearmament cycle (Investing.com).
Sensors & Information segment revenue dropped 12% year-on-year and operating profit fell 26% in H1 2025 because of delays in UK defence spending decisions, marking a significant area of weakness (Investing.com).
Net debt increased to £93.3 million from £75.3 million in the first half, due to heavy investment in expanding energetic materials capacity, and raising leverage that could limit financial flexibility (Investing.com).
A lack of clear timing or funding details in the UK Strategic Defence Review creates execution risk for Chemring's expected growth projects, potentially tempering future expectations (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.

Chemring Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Chemring Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £CHG

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs